knowledge -WSS

knowledge

author：explore 2025-09-29 22:52:02 - browse：7

RHONA WISE/AFP via Getty Images

WASHINGTON — Drugmakers are doing everything to tap the bottomless well of demand for new obesity drugs, and they might get some government help. The agency that regulates Obamacare insurance is considering a technical change that would require insurers to cover obesity drugs in a market of more than 20 million Americans.

Weight loss drugs are a blessing for patients, a boon for drugmakers, and a potentially huge expense for insurers and taxpayers. Insurers have been slow to cover the drugs, called GLP-1 agonists, and without insurance, it costs upward of $16,000 annually for a drug that must be taken indefinitely.

There is a lot of demand for the drugs, but there are barriers to coverage. Medicare by law is prohibited from paying for obesity drugs. State Medicaid programs don’t have to cover them, so most don’t.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Senate panel to vote on hospitals, PBMs, prisoner care

entertainment

WSS

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Study fuels hope CAR

Redefining sustainability for the pharmaceutical industry

CDC panel: People 65 and older should get a Covid spring booster shot

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

First Opinion Podcast: How to protect health care in times of war

explore

knowledge

explore

Jerome Adams on the need for new antivirals for Covid

Diversifying clinical trials isn't enough to close racial gaps: study

Virginia high school admissions case could be legal follow

Emergency medicine has repudiated 'excited delirium.' Now what?

Peter Hotez and the public health issue of online harassment

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Dobbs anniversary: the lost opportunity of abortion as health care

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Guidelines to prevent youth baseball injuries need more muscle

The FDA weighs the risks of candy

Wikipedia

Testing for cancer recurrence creates a new limbo for patients

Children’s Hospital revives plan for pedestrian bridge

Medicare Advantage isn’t working — for anyone

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Study fuels hope CAR

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

entertainment

explore

explore

hotspot